Sabril 500 Tablets contain Vigabatrin, a potent anticonvulsant used for managing epilepsy, particularly complex partial seizures and infantile spasms in infants. These tablets function by inhibiting the enzyme responsible for the breakdown of gamma-aminobutyric acid (GABA), increasing its concentration in the brain to reduce nerve excitability and control seizure activity. Sabril 500 is prescribed by neurologists and pediatricians to patients displaying refractory epilepsy symptoms that do not respond adequately to conventional therapies. The dosage is carefully tailored to patient-specific factors and must be followed strictly to achieve optimal seizure control and minimize risks. Sabril is produced under rigorous pharmaceutical manufacturing standards to assure purity, consistency, and safety. Patients are advised to undergo regular ophthalmologic exams during treatment due to the risk of vision impairment associated with Vigabatrin. This medication is an essential therapeutic tool in specialized epilepsy management centers for improving quality of life in affected patients.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Vigabatrin |
| Dosage Strength | 500 mg per tablet |
| Therapeutic Use | Management of complex partial seizures and infantile spasms |
| Mechanism of Action | Inhibits GABA transaminase to increase GABA levels in the brain |
| Manufacturing Standards | Produced under stringent pharmaceutical quality controls |
| Patient Monitoring | Requires periodic vision testing to detect early side effects |
| Prescription Requirement | Available only on prescription |
| Packaging | Available in blister packs with specified tablet counts |
| Attributes | Description |
|---|---|
| Active Pharmaceutical Ingredient (API) | Vigabatrin 500 mg |
| Formulation | Oral Tablets |
| Tablet Shape and Color | White, round tablets |
| Route of Administration | Oral |
| Storage Conditions | Store below 30°C, protect from moisture and light |
| Shelf Life | Typically 24 months from manufacture |
| Packaging | Blister pack with variable tablet counts |
| Indications | Epilepsy - complex partial seizures, infantile spasms |
| Side Effects to Monitor | Vision changes, dizziness, headache |
| Regulatory Status | Prescription-only medicine |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Patients on Sabril should undergo routine ophthalmic examinations before starting treatment and periodically thereafter to monitor for potential vision impairment caused by Vigabatrin.
Yes, Sabril 500 Tablets are indicated for infantile spasms; however, dosing must be precisely controlled and supervised by a healthcare professional experienced in pediatric epilepsy.
The primary side effect to be cautious about is visual field constriction, which can be permanent if not monitored properly, along with dizziness and headache.
No, Sabril 500 Tablets are prescription-only due to the need for controlled dosing and patient monitoring.
Vigabatrin specifically inhibits GABA transaminase, increasing GABA concentration in the brain, which differentiates it from other antiepileptics that act via different mechanisms.
Inclusive of all taxes
You Save: 0
Bengaluru , India
Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler
GST- 29AQTPJ8785C1Z2
